Moreover, in CRC, METTL3 enhances plasminogen activator, urokinase (PLAU) expression, which activates angiogenic factors stored in the ECM, thereby facilitating angiogenesis [51, 52]. This evidence concerns the gene METTL3 and colorectal carcinoma.